Copyright
©2012 Baishideng Publishing Group Co.
World J Cardiol. Jan 26, 2012; 4(1): 8-14
Published online Jan 26, 2012. doi: 10.4330/wjc.v4.i1.8
Published online Jan 26, 2012. doi: 10.4330/wjc.v4.i1.8
Table 4 Follow-up echocardiographic evaluation of the prosthetic valve (mean follow-up 14.7 mo)
| AF group | SR group | P | |
| Aortic valve area (cm2, mean) | 1.66 | 2.05 | 0.18 |
| Peak gradient (mmHg, mean) | 18.6 | 19.3 | 0.86 |
| Mean gradient (mmHg, mean) | 9.5 | 11.0 | 0.51 |
| LVEF (mean) | 59% | 62.9% | 0.14 |
| Valvular aortic regurgitation | |||
| No | 70% | 66.7% | - |
| Mild | 30% | 33.3% | - |
| Moderate | 0% | 0% | - |
| Severe | 0% | 0% | - |
| Paravalvular aortic regurgitation | |||
| No | 10% | 55.6% | - |
| Mild | 70% | 44.4% | - |
| Moderate | 20% | 0% | - |
| Severe | 0% | 0% | - |
- Citation: Salinas P, Moreno R, Calvo L, Jiménez-Valero S, Galeote G, Sánchez-Recalde A, López-Fernández T, Garcia-Blas S, Iglesias D, Riera L, Moreno-Gómez I, Mesa JM, Plaza I, Ayala R, Gonzalez R, López-Sendón JL. Clinical and prognostic implications of atrial fibrillation in patients undergoing transcatheter aortic valve implantation. World J Cardiol 2012; 4(1): 8-14
- URL: https://www.wjgnet.com/1949-8462/full/v4/i1/8.htm
- DOI: https://dx.doi.org/10.4330/wjc.v4.i1.8